IGF::OT::IGF ANTHRAX VACCINE
$1,174,464,339
| Recipient | EMERGENT BIODEFENSE OPERATIONS LANSING LLC UEI MUM1EGCDWZJ4 |
|---|---|
| Award ID | HHSD200201792634C |
| Award amount | $1,174,464,339 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| PSC | 6505 |
| Set-aside | Unrestricted |
| Start date | Dec 8, 2016 |
| End date | Jun 30, 2022 |
| Place of performance | LANSING, MI |
| Record updated | Jun 16, 2022 |
View the official award record
More awards won by EMERGENT BIODEFENSE OPERATIONS LANSING LLC
CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL
Department of Health and Human Services · $213,770,068 · Aug 29, 2022
PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ADSORBED)
Department of Defense · $41,801,810 · Jan 22, 2024
FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))
Department of Defense · $21,534,000 · Jan 4, 2026
PROCUREMENT OF BIOTHRAX
Department of Defense · No current value reported · Jan 9, 2024
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids